Name and surname:
|
RNDr. Michal Konečný, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
Laboratory diagnostician in clinical genetics, head of the department | Department of Clinical Genetics, St. Elizabeth Cancer Institute, Bratislava | 2003-2016 |
Professional director | GHC Genetics, Prague | 2017 |
Professional director | Laboratory od Genomics Medicine, GHC GENETICS SK, Bratislava | 2018-actual |
Professional assistant | Department of Biology, Faculty of Natural Sciences, University of Ss. Cyril and Methodius | 2019-actual |
Professional assistant | Department of Genetics, Faculty of Natural Sciences, Comenius University, Bratislava | 2022-actual |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
Specialization in the specialized field Laboratory and Diagnostic methods in Clinical Genetics | Slovak Medical University in Bratislava, Limbová 12, 833 03 Bratislava | 2010 |
Specialization in Healthcare Management and Financing | Slovak Medical University in Bratislava, Limbová 12, 833 03 Bratislava | 2017 |
Allocation of scientific qualification level IIa | Slovak Academy of Sciences, Bratislava | 2021 |
Training course for next generation sequencing and applications | Roche, Mannheim, GER | 2013 |
Educational training for sequencing applications on ABI 3130 | Applied Biosystems, Manchester, UK | 2006 |
Rare disease workshop | EUCERD, Roma, IT | 2012 |
Rare Diseases Europe Roundtable | EUCERD, Brussels, BEL | 2016 |
Chairman of the professional genetics society | Slovak Society of Medical Genetics | 2018-2022, 2022-actually |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
Applied genetics | Biology | 2. | Genetics |
Konecny, M., Kosova, K., Tilandyova, P., ...Markus, J., Ciernikova, S. The results of multigene panel
sequencing in Slovak HBOC families. Neoplasma, 2021, 68(3), pp. 652–664
Konecny, M., Markus, J., Waczulikova, I., ...Novosadova, H., Majer, I. The value of SHOX2
methylation test in peripheral blood samples used for the differential diagnosis of lung cancer and
other lung disorders. Neoplasma, 2016, 63(2), pp. 246–253.
Konecny, M., Milly, M., Zavodna, K., ...Kausitz, J., Bartosova, Z. Comprehensive genetic
characterization of hereditary breast/ovarian cancer families from Slovakia. Breast Cancer Research
and Treatment, 2011, 126(1), pp. 119–130.
Konecny, M., Vizvaryova, M., Zavodna, K., ...Kausitz, J., Weismanova, E. Identification of a novel
mutations Brca1*c.80 + 3del4 and Brca2*c.6589delA in Slovak HBOC families. Breast Cancer
Research and Treatment, 2010, 119(1), pp. 233–237.
Konecny, M., Zavodna, K., Vranova, V., ...Kausitz, J., Bartosova, Z. Identification of rare complete
BRCA1 gene deletion using a combination of SNP haplotype analysis, MLPA and array-CGH
techniques. Breast Cancer Research and Treatment, 2008, 109(3), pp. 581–583
Konecny, M., Kosova, K., Tilandyova, P., ...Markus, J., Ciernikova, S. The results of multigene panel
sequencing in Slovak HBOC families. Neoplasma, 2021, 68(3), pp. 652–664
Zidekova, D., Waczulikova, I., Dolesova, L., ...Lohajova Behulova, R., Konecny, M. Rapid screening
test of most frequent BRCA1/BRCA2 pathogenic variants in the NGS era. Neoplasma, 2018, 65(2), pp.
309–315
Duan, J., Zhong, B., Fan, Z., ...Zhang, X., Sanders, Y.Y. DNA methylation in pulmonary fibrosis and
lung cancer. Expert Review of Respiratory Medicine, 2022, 16(5), pp. 519–528
Le, T.-N.N., Tran, V.-K., Nguyen, T.-T., ...Ta, T.-V., Tran, H.-T. BRCA1/2 Mutations in Vietnamese
Patients with Hereditary Breast and Ovarian Cancer Syndrome. Genes, 2022, 13(2), 268
Rajabi, F., Mozdarani, H. Expression level of miR-155, miR-15a and miR-19a in peripheral blood of
ductal carcinoma breast cancer patients: Possible bioindicators for cellular inherent
radiosensitivity. Experimental and Molecular Pathology, 2022, 126, 104758
Wen, S.W.C., Wen, J., Hansen, T.F., Jakobsen, A., Hilberg, O. Cell Free Methylated Tumor DNA in
Bronchial Lavage as an Additional Tool for Diagnosing Lung Cancer—A Systematic Review. Cancers,
2022, 14(9), 2254
Yuan, L., Wang, L., Du, X., ...Qin, X., Liu, C. The DNA methylation of FOXO3 and TP53 as a blood
biomarker of late-onset asthma. Journal of Translational Medicine, 2020, 18(1), 4
Building a Competence Center for Research and Development in the Field of Molecular Medicine
[ITMS 26240220071] - EU ŠF
APVV-20-0070, Sex-specific genetic-endocrine perspective on autism spectrum disorders